Fate Therapeutics, Inc. Share Price
FATEFate Therapeutics, Inc. Stock Performance
Open $2.15 | Prev. Close $2.10 | Circuit Range N/A |
Day Range $2.08 - $2.47 | Year Range $0.91 - $2.88 | Volume 1,45,408 |
Average Traded $2.37 |
Fate Therapeutics, Inc. Share Price Chart
About Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Fate Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $2.15 | $2.41 | +0.00% |
29-Jun-26 | $2.15 | $2.41 | +15.04% |
26-Jun-26 | $1.86 | $2.10 | +13.24% |
25-Jun-26 | $2.08 | $1.85 | -9.76% |
24-Jun-26 | $2.17 | $2.05 | -5.53% |
23-Jun-26 | $2.14 | $2.17 | +1.40% |
22-Jun-26 | $2.09 | $2.14 | +2.88% |
FAQs on Fate Therapeutics, Inc. Share Price
Can I buy Fate Therapeutics, Inc. shares in India?
What is the share price of Fate Therapeutics, Inc.?
What is the 5 year returns of Fate Therapeutics, Inc.?
What are the high & low stock price of Fate Therapeutics, Inc. today?
What is the 52-week high and low of Fate Therapeutics, Inc. stock?